Skip to content
The Nexus
DossierENTITY

Chinese pharmaceutical companies

Coverage of Chinese pharmaceutical companies in the Nexus archive.

Earliest in view: Jul 28 · 10:39 UTCMost recent: Jul 28 · 10:39 UTC
Co-mentioned in this coverage
AstraZenecaorganization1Dr. Aradhana Sarinperson1GLP-1 drugstopic1colorectal cancertopic1Endometrial cancertopic1Pascal Soriotperson1pharma out-licensingtopic1
Recent coverage
  • BUSINESSJul 28 · 10:39 UTCSEMAFOR
    China’s up-and-coming pharma giants

    Chinese pharmaceutical companies are advancing in early-stage research and clinical trials but remain about a decade behind global leaders like AstraZeneca. AstraZeneca's CFO, Aradhana Sarin, noted that Chinese firms lack the capability for global clinical trials but may challenge Western competitors within 10 years. The rise of GLP-1 drugs for weight loss could reshape pharmaceutical strategies and cancer prevalence patterns.

Chinese pharmaceutical companies · Dossier · The Nexus